Schrodinger
Provides physics based software solutions to accelerate molecular discovery and design.
What they do
Schrodinger offers a computational physics platform that simulates molecular behavior at atomic scale. Pharmaceutical and biotechnology companies use this software to predict the properties of potential drug molecules, reducing the cost and time of early stage chemical synthesis.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- Computational chemistry
- Product type
- Platform software
- Stage
- Public
- Headquarters
- New York, United States
- Region
- North America
- Founded
- 1990
- Total funding
- $410M raised
Notable investors: Bill & Melinda Gates Foundation, Deerfield Management, Baron Capital.